EFFECTS OF MEMBRANESTABILIZING MAGNETOLASER THERAPY ON CARDIODYNAMICSIN PATIENTS WITH ISCHEMIC HEART DISEASE

EFFECTS OF MEMBRANESTABILIZING MAGNETOLASER THERAPY ON CARDIODYNAMICSIN PATIENTS WITH ISCHEMIC HEART DISEASE

Aim. To evaluate cardiodynamic changes in response to magnetolaser therapy (MLT) and these changes links with lipid shifts in cell membrane. Material and methods. The study enrolled 50 patients with effort angina (functional class 11-III). Of them, 37 patients were exposed to 10-day courses of MLT,...

Full description

Bibliographic Details
Main Authors:	A P Vasilyev, Yu N Senatorov, N N Streltsova, M V Malishevsky, T V Dubova, E L Zykova
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2003-12-01
Series:	Терапевтический архив
Subjects:	ischemic heart disease cell membrane magnetolaser therapy cardiac remodeling
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/29695

Similar Items

MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE
by: A. N. Zakirova, et al.
Published: (2016-01-01)

RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
by: A. I. Chesnikova, et al.
Published: (2016-01-01)

Features of structural and geometric remodeling of the heart and changes in the diastolic filling of the heart in patients with chronic heart failure of ischemic genesis with preserved left ventricular ejection fraction
by: V. A. Lysenko, et al.
Published: (2021-03-01)

Features of structural heart remodeling in chronic atrial fibrillation against the background of coronary artery disease with hypertension
by: N N Mironchuk, et al.
Published: (2018-04-01)

Features of structural heart remodeling in chronic atrial fibrillation against the background of coronary artery disease with hypertension
by: N.N. Mironchuk, et al.
Published: (2018-04-01)

Features of structural and geometric remodeling of the heart and changes in heart diastolic filling in patients with chronic heart failure of ischemic genesis with reduced left ventricular ejection fraction
by: V. A. Lysenko
Published: (2021-02-01)

CHARACTERISTICS OF THE TYPES OF LEFT VENTRICULAR REMODELING AMONG WORKING AGE MEN WITH ISCHEMIC HEART DISEASE, LIVING IN ONE OF THE MOUNTAIN REGIONS OF AZERBAIJAN
by: N. R. Ismaylova, et al.
Published: (2015-09-01)

THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE
by: I. V. Sergienko, et al.
Published: (2015-12-01)

THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015-09-01)

Biochemical algorithms of early diagnostic of metabolic remodeling and cardiac hypertrophy in patients with diabetic mellitus and chronic heart failure cause by ischemic heart disease
by: O. P. Donetskaya, et al.
Published: (2019-08-01)

Evaluation of ischemic heart disease and viability by cardiac MRI
by: Mona Bhatia
Published: (2014-01-01)

Structural and functional characteristics of healthy heart and their interrelations with vegetative heart regulation
by: E. M. Khurs, et al.
Published: (2011-02-01)

The role of cardiovascular rehabilitation in women with ischemic heart disease and rhythm disorders
by: Diana Gurzău, et al.
Published: (2018-05-01)

Decreased cardiac mortality with nicorandil in patients with ischemic heart failure
by: Akiomi Yoshihisa, et al.
Published: (2017-05-01)

Effects of chronic airway obstruction and atrial fibrillation on the cardiac structure and function in patients with heart failure
by: A. I. Chesnikova, et al.
Published: (2020-03-01)

Effect of Danhong injection on neuroendocrine molecules and ventricular remodeling in patients with ischemic cardiomyopathy heart failure
by: Lin Sun, et al.
Published: (2017-07-01)

THE REMODELING OF LEFT ATRIUM AND VASODILATION FACTORS CHANGES IN ISCHEMIC HEART FAILURE
by: V. I. Denesyuk, et al.
Published: (2017-02-01)

Is there the phenotype of chronic heart failure with “intermediate” left ventricular ejection fraction? Additional echocardiographic criteria for left ventricular systolic dysfunction in patients with chronic heart failure of ischemic origin with ejection fraction in the “gray area”
by: V. V. Syvolap, et al.
Published: (2021-06-01)

Melatonin in Heart Failure: A Promising Therapeutic Strategy?
by: Frederic Nduhirabandi, et al.
Published: (2018-07-01)

Novel Molecular Approaches in Heart Failure: Seven Trans-membrane Receptors Signaling in the Heart and Circulating Blood Leucocytes
by: Gabriele Giacomo Schiattarella, et al.
Published: (2015-03-01)

Cardiac Regeneration: New Insights Into the Frontier of Ischemic Heart Failure Therapy
by: Andrew S. Riching, et al.
Published: (2021-01-01)

Gender differences among ischemic heart disease patients enrolled in a cardiac rehabilitation program
by: Ahmed Mohamed El Missiri, et al.
Published: (2020-03-01)

MODELING OF THE 10-YEAR SURVIVAL OF MEN 60 YEARS AND OLDER, WITH ISCHEMIC HEART DISEASE
by: I. V. Tancyreva, et al.
Published: (2015-08-01)

LOVASTATIN EFFECT ON VASCULAR REMODELING AND MYOCARDIAL SYSTOLIC AND DIASTOLIC FUNCTION IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
by: A. S. Kerimkulova, et al.
Published: (2016-01-01)

Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy
by: Hisashi Yokoshiki, MD, PhD, et al.
Published: (2017-10-01)

Discrepancy between MRI and echocardiography in assessing functional left ventricular parameters and scar characteristics in patients with chronic ischemic cardiomyopathy
by: Sherif Gouda, et al.
Published: (2015-09-01)

PATHOGENESIS OF COLD ISCHEMIA IN CORONARY PATIENTS
by: A. P. Vasilyev, et al.
Published: (2002-10-01)

Percutaneous Ventricular Restoration Therapy Using the Parachute Device in Chinese Patients with Ischemic Heart Failure: Three-Month Primary End-point Results of PARACHUTE China Study
by: Yue-Jin Yang, et al.
Published: (2016-01-01)

Zebrafish Heart Failure Models
by: Suneeta Narumanchi, et al.
Published: (2021-05-01)

Criteria of eligibility of patients with ischemic cardiomyopathy for revascularization and other surgical procedures
by: N.D. Oryshchyn
Published: (2016-09-01)

Sudden Cardiac Death in Adult Patients with Stable Ischemic Heart Disease
by: C. Richard Conti, MD, MACC
Published: (2019-01-01)

Left Ventricular Dysfunction in Ischemic Heart Disease
by: Robert F. Hamburger, DO, MPH, FACC
Published: (2019-01-01)

Magnetic Resonance Imaging in Myocardial Fibrosis Related to Ischemic Events
by: Himcinschi Elisabeta, et al.
Published: (2017-09-01)

How do I track Cardiac Rehabilitation in my patient with ischemic heart disease using Strava
by: Oana Moldovan, et al.
Published: (2019-05-01)

Assessing autonomic nervous function by heart rate variability and heart rate turbulence in patients with acute ischemic stroke
by: Mustafa Candemir, et al.
Published: (2020-01-01)

Disconnect Between Genes Associated With Ischemic Heart Disease and Targets of Ischemic Heart Disease Treatments
by: C.M. Schooling, et al.
Published: (2018-02-01)

NITRATES IN ISCHEMIC HEART DISEASE TREATMENT, YESTERDAY AND TODAY
by: S. N. Tereschenko, et al.
Published: (2015-12-01)

COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES
by: A. N. Sumin, et al.
Published: (2017-11-01)

Optimization of treatment of patients with ischemic heart disease after suffering intervention in the coronary arteries
by: Y. I. Karpenko, et al.
Published: (2016-08-01)

The Current Dilemma and Breakthrough of Stem Cell Therapy in Ischemic Heart Disease
by: Chuanbin Liu, et al.
Published: (2021-04-01)